These data therefore assume an important role of the TNFα/TNFR1 pathway in the activation of SREBP-1 and hepatic fatty acid synthesis in mice with NAFLD. This evidence concerns the gene TNFRSF1A and metabolic dysfunction-associated steatotic liver disease.